Live feed
·
INSIDERFilingvia Quantisnow
Enzo Biochem Inc. logo

Enzo Biochem (ENZ) director Radoff bought 12,500 shares for $28.4K at $2.27

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Bradley Louis Radoff (director at Enzo Biochem Inc., ENZ) reported that they bought 12,500 shares for $28.4K at $2.27 on Jul 12, 2022. After these transactions the filing shows 4,194,663 shares held directly.

Reporting person
Radoff Bradley Louis
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jul 12, 2022Open-market purchase (P)Common Stock, $0.01 Par Value+12,500$2.27$28.4K4,194,663 direct

Holdings before and after

  • Common Stock, $0.01 Par Value: 4,182,163 to 4,194,663 direct

Other positions listed

  • Common Stock, $0.01 Par Value: 430,000 indirect, By The Radoff Family Foundation

Transaction codes in this filing

Open-market purchase:
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ

What did Radoff report in this ENZ Form 4?

Bradley Louis Radoff (director at Enzo Biochem Inc., ENZ) reported that they bought 12,500 shares for $28.4K at $2.27 on Jul 12, 2022. After these transactions the filing shows 4,194,663 shares held directly.

How many ENZ shares does Radoff hold after this filing?

The filing shows 4,194,663 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code P mean on an SEC Form 4?

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

Historical context for ENZ

Earlier insider filings at ENZ

Quantisnow market dataNYSE
Enzo Biochem Inc. logo
ENZ
Enzo Biochem Inc.
Market cap
30-day
Sector
Health Care
Industry
Medical Specialities
Listed since
1988
Get push alerts for ENZ

Follow ENZ and get a push notification the moment its next story breaks.

Full ENZ profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENZ (Enzo Biochem Inc.) and more on Quantisnow.